Valor IV Pharma Holdings LLC 13D and 13G filings for Harmony Biosciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 6:10 pm Sale | 2024-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Valor IV Pharma Holdings LLC | 6,654,747 11.700% | -4,592,686 (-40.83%) | Filing |
| 2024-02-13 7:06 pm Purchase | 2023-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Valor IV Pharma Holdings LLC | 11,247,433 19.200% | 10,845 (+0.10%) | Filing |
| 2023-02-13 5:04 pm Purchase | 2022-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Valor IV Pharma Holdings LLC | 11,236,588 18.900% | 14,350 (+0.13%) | Filing |
| 2022-02-10 4:46 pm Purchase | 2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Valor IV Pharma Holdings LLC | 11,222,238 19.200% | 4,205 (+0.04%) | Filing |
| 2021-02-16 06:54 am Purchase | 2020-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Valor IV Pharma Holdings LLC | 11,218,033 19.700% | 11,218,033 (New Position) | Filing |